Some of Kind’s patent applications do cover the possibility of producing these organ sacks from human cells. Rebo says that’s more of a speculative possibility. But he does see his work as part of the “replacement” approach to longevity. Firstly, that’s because a “scalable production of young, high-quality organs” would let surgeons try transplants in more types of patients, including many with heart disease in old age who aren’t candidates for a transplant now.
Актуальные события
，详情可参考有道翻译
Поделитесь мнением! Оставьте оценку!
除自身利润外，去年九月企业推出员工跟投计划，最低投资门槛一万元。通过股权绑定既激发员工积极性，也增强归属感。